Aldeyra Therapeutics, Inc. reports

Company location: Lexington, MA
Fiscal year end: 31 December

Aldeyra Therapeutics, Inc. has filed 645 SEC EDGAR filings since 06 Oct 2005

Filter by type:
10-K
10-Q
8-K
SC13G

SEC filing history

Showing 126-150 of 643 matching filings.

Per page

25

Current page

6

8-K File 001-36332

8-K

Filing date: 28 Nov 2023
Reporting date: 27 Nov 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

S-8 File 333-275315

S-8

Filing date: 03 Nov 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 001-36332

10-Q

Filing date: 03 Nov 2023
Reporting date: 30 Sep 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-36332

8-K

Filing date: 01 Nov 2023
Reporting date: 31 Oct 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

SC 13G/A File 005-88182

SC 13G/A

Filing date: 19 Oct 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date: 18 Oct 2023
Reporting date: 16 Oct 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-36332

8-K

Filing date: 16 Oct 2023
Reporting date: 10 Oct 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

SC 13G File 005-88182

SC 13G

Filing date: 04 Oct 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 11 Sep 2023
Reporting date: 07 Sep 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 11 Sep 2023
Reporting date: 07 Sep 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 24 Aug 2023
Reporting date: 22 Aug 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 001-36332

10-Q

Filing date: 03 Aug 2023
Reporting date: 30 Jun 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

4

Filing date: 05 Jul 2023
Reporting date: 30 Jun 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 05 Jul 2023
Reporting date: 30 Jun 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 05 Jul 2023
Reporting date: 30 Jun 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 05 Jul 2023
Reporting date: 30 Jun 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 05 Jul 2023
Reporting date: 30 Jun 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 05 Jul 2023
Reporting date: 30 Jun 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-36332

8-K

Filing date: 03 Jul 2023
Reporting date: 30 Jun 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 29 Jun 2023
Reporting date: 27 Jun 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-36332

ALDEYRA THERAPEUTICS, INC. 8-K

Filing date: 29 Jun 2023
Reporting date: 29 Jun 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-36332

ALDEYRA THERAPEUTICS, INC. 8-K

Filing date: 27 Jun 2023
Reporting date: 27 Jun 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-36332

ALDEYRA THERAPEUTICS, INC. 8-K

Filing date: 21 Jun 2023
Reporting date: 21 Jun 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-36332

ALDEYRA THERAPEUTICS, INC. 8-K

Filing date: 15 Jun 2023
Reporting date: 15 Jun 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

ARS File 001-36332

ARS

Filing date: 24 May 2023
Reporting date: 31 Dec 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .